Department of Medicine receives record-breaking research funding

More than 190 Emory University Department of Medicine investigators brought in a record $104.7 million in sponsored research funding in Fiscal Year 16, an increase of 12.8 percent over FY15 ($92.8 million). Investigators received an additional $9.4 million in funding from the Atlanta VA Medical Center and the Atlanta Research & Education Foundation (AREF)

funding

Breakdown by division (FY16):

Division Research funding (dollars)
ACTSI 6.2 million
Cardiology 18.5 million
Digestive Diseases 3.2 million
Endocrinology 4.2 million
General Medicine 2.5 million
Geriatrics 7.2 million
Hospital Medicine 100,000+
Infectious Diseases 47.7 million
Renal Medicine 3.8 million
Pulmonary 6.6 million
Rheumatology 4.7 million
~104.7 million

 

Note: The Atlanta Clinical & Translational Science Institute (ACTSI) of Emory University is part of a national consortium striving to improve the way biomedical research is conducted across the country. The consortium, funded through the NIH’s Clinical and Translational Science Awards (CTSA), shares a common vision to translate laboratory discoveries into treatments for patients, engage communities in clinical research efforts, and train the next generation of clinical investigators.

The Department of Medicine places strong emphasis on its broad and innovative research programs. The nine Emory University Department of Medicine divisions (and ACTSI) perform basic, translational, and clinical research related to physiology, therapeutics, and disease pathogenesis. Our basic scientists, clinical researchers, and clinicians work side-by-side to address fundamental problems in human disease. For more information, visit our website.

 

Related Links

Be the first to comment on "Department of Medicine receives record-breaking research funding"

Leave a comment

Your email address will not be published.




Share(s)